From: Heat shock protein expression in canine malignant mammary tumours
 | Histological diagnosis | Overall Survival (months) |
---|---|---|
n° 1 | in situ carcinoma | 23 |
n° 2 | in situ carcinoma | 22 |
n° 3 | in situ carcinoma | 36 |
n° 4 | in situ carcinoma | 29 |
n° 5 | in situ carcinoma | 24 |
n° 6 | in situ carcinoma | 27 |
n° 7 | in situ carcinoma | 23 |
n° 8 | in situ carcinoma | 29 |
n° 9 | in situ carcinoma | 60 |
n° 10 | in situ carcinoma | 28 |
STAGE I | ||
n° 1 | simple solid carcinoma | 24 |
n° 2 | simple tubular carcinoma | 27 |
n° 3 | carcinoma in benign tumour | 22 |
n° 4 | simple tubulopapillary carcinoma | 27 |
n° 5 | carcinoma in benign tumour | 22 |
n° 6 | simple solid carcinoma | 26 |
n° 7 | simple tubulopapillary carcinoma | 33 |
n° 8 | complex carcinoma | 24 |
n° 9 | simple tubulopapillary carcinoma | 28 |
n° 10 | simple carcinoma | 42 |
STAGE II | ||
n° 1 | simple tubulopapillary carcinoma | 36 |
n° 2 | simple solid carcinoma | 4 |
n° 3 | simple solid carcinoma | 1 |
n° 4 | simple solid carcinoma | 26 |
n° 5 | simple solid carcinoma | 9 |
n° 6 | simple solid carcinoma | 24 |
n° 7 | simple solid carcinoma | 1 |
n° 8 | carcinoma in benign tumour | 12 |
n° 9 | simple tubulopapillary carcinoma | 2 |
n° 10 | simple solid carcinoma | 26 |